The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors
2011

Impact of Cancer Mutations on Protein Structure

Sample size: 1992 publication Evidence: high

Author Information

Author(s): Henning Stehr, Seon-Hi Jang, José M. Duarte, Christoph Wierling, Hans Lehrach, Michael Lappe, Bodo M. H. Lange

Primary Institution: Max-Planck Institute for Molecular Genetics

Hypothesis

The study investigates the structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors.

Conclusion

The study confirms that distinct mutational patterns in oncogenes and tumor suppressors can be used to pre-classify newly identified cancer-associated genes.

Supporting Evidence

  • Mutations in oncogenes are more often found on the surface of proteins.
  • Tumor suppressor mutations are frequently destabilizing.
  • Oncogenes show a tendency to target functional sites more than tumor suppressors.
  • Cancer mutations in oncogenes are highly clustered compared to those in tumor suppressors.

Takeaway

Cancer mutations can change how proteins work, and by studying these changes, we can better understand cancer and identify new cancer genes.

Methodology

The study analyzed ~2000 cancer-associated mutations in oncogenes and tumor suppressors, focusing on structural features such as solvent accessibility and protein stability.

Potential Biases

The analysis may be biased due to the inclusion of genes with few mutations.

Limitations

The dataset may contain passenger mutations, which could affect the results.

Participant Demographics

The study focused on mutations from eight common cancer types.

Statistical Information

P-Value

2e-5

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-4598-10-54

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication